Sort by: Date / Relevance
IGJ information about clinical trials in the Netherlands
Coronavirus (COVID-19): impact on the conduct of clinical trials under the Medical Research Involving Human Subjects Act (WMO)
The information below is valid during the COVID-19 pandemic until the situation is normalised and this is stated on the website ...
Instruction to register the supply of alternative medical devices
A manufacturer, authorised representative, distributor, or importer can register the supply of an alternative medical device with ...
GLP domestic test facilities
GLP-Non-domestic test facilities
IGJ position as a result of the ANSM decision relating to breast implants
With this letter, the Health and Youth Care Inspectorate [Inspectie Gezondheidszorg en Jeugd] (IGJ) informs the Minister for ...
Domestic test facilities
C: Mandatory notification of clinical investigations involving the use of medical devices
Cross border pharmacies
In the Netherlands, some pharmacies provide prescription medicines to people who live in other EU member states. Those pharmacies ...
IGJ position on textured and smooth breast implants and BIA-ALCL
At the beginning of this year, scientific research was published that shows that there is a link between a certain type of cancer ...